StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

(S)-[2-[[2-(2-Chlorobenzoyl)-4-nitrophenyl]amino]-1-methyl-2-oxoethyl]-carbamic Acid Phenylmethyl Ester → Meclonazepam

HRID 1632168
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 1632168
C(OC(=O)[NH:10][C@H:11]([C:13](=[O:33])[NH:14][C:15]1[CH:20]=[CH:19][C:18]([N+:21]([O-:23])=[O:22])=[CH:17][C:16]=1[C:24](=O)[C:25]1[CH:30]=[CH:29][CH:28]=[CH:27][C:26]=1[Cl:31])[CH3:12])C1C=CC=CC=1>Br.C(O)(=O)C>[Cl:31][C:26]1[CH:27]=[CH:28][CH:29]=[CH:30][C:25]=1[C:24]1[C:16]2[CH:17]=[C:18]([N+:21]([O-:23])=[O:22])[CH:19]=[CH:20][C:15]=2[NH:14][C:13](=[O:33])[C@H:11]([CH3:12])[N:10]=1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

4

Edukt 1

HCID 131713833(S)-[2-[[2-(2-Chlorobenzoyl)-4-nitrophenyl]amino]-1-methyl-2-oxoethyl]-carbamic Acid Phenylmethyl Ester

Produkt 1

HCID 3033985Meclonazepam

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 176Acetic AcidLösungsmittelHCID 260Hydrogen BromideLösungsmittel

Versuchsvorschrift

130 g (0.27 mol) of (S)-benzyl-[1-[[2-(o-chlorobenzoyl)-4-nitrophenyl]carbamoyl]ethyl]carbamate are dissolved in 350 ml of a 30 to 33 percent solution of hydrogen bromide in glacial acetic acid, the solution is stirred at room temperature for 30 minutes, evaporated, treated with water and extracted three times with ether. The aqueous solution is cooled in ice, neutralized with solid sodium bicarbonate and extracted with methylene chloride. The organic phase is dried over sodium sulphate and evaporated. The residue is treated with 80 ml of glacial acetic acid and 800 ml of toluene, the mixture is heated to boiling under reflux for 20 minutes and then evaporated. The residual oil is taken up in methylene chloride, washed with saturated sodium bicarbonate solution, dried over sodium sulphate and evaporated. The residue is dissolved in 500 ml of benzene, the solution is seeded with racemic 5-(o-chlorophenyl)-1,3-dihydro-3-methyl-7-nitro-2H-1,4-benzodiazepin-2-one and left to stand at room temperature overnight. The crystalline material is filtered off and the mother liquor is evaporated. After recrystallization of the residue from ether, there is obtained (S)-5-(o-chlorophenyl)-1,3-dihydro-3-methyl-7-nitro-2H-1,4-benzodiazepin-2-one of melting point 200°-202°; [α]25D =+241° (1 percent solution in methylene chloride).

Aufarbeitung

  1. customevaporated
  2. additiontreated with water
  3. extractionextracted three times with ether
  4. temperatureThe aqueous solution is cooled in ice
  5. extractionextracted with methylene chloride
  6. dry with materialThe organic phase is dried over sodium sulphate
  7. customevaporated
  8. additionThe residue is treated with 80 ml of glacial acetic acid and 800 ml of toluene
  9. temperaturethe mixture is heated
  10. temperatureunder reflux for 20 minutes
  11. customevaporated
  12. washwashed with saturated sodium bicarbonate solution
  13. dry with materialdried over sodium sulphate
  14. customevaporated
  15. dissolutionThe residue is dissolved in 500 ml of benzene
  16. waitleft
  17. waitto stand at room temperature overnight
  18. filtrationThe crystalline material is filtered off
  19. customthe mother liquor is evaporated
  20. customAfter recrystallization of the residue from ether

Quellen und Nachweise

ORD-Eintrag
ord-53254f2a4ff745ce88f27b4211118ec4
Quelldatensatz
uspto-grants-1984_10
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US04474777

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion